Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronika Bahlinger

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Virchows Archiv : an International Journal of Pathology|July 19, 2024
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancerFabienne Lange, Carol I Geppert, Veronika Bahlinger, et al.
Immunotargets and Therapy|May 7, 2026
B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile CancerAleksander Kielbik, Veronika Bahlinger, Christian M Schürch, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
International Journal of Molecular Sciences|September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and SubtypingStefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Frontiers in Immunology|October 29, 2024
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevanceAnnalena Branz, Christian Matek, Fabienne Lange, et al.
Communications Biology|December 30, 2025
Nanosecond pulsed electric fields induce cell-size-dependent selective permeabilization of urothelial cancer cellsAleksander Kielbik, Emily Hellwich, Veronika Bahlinger, et al.
Virchows Archiv : an International Journal of Pathology|August 27, 2024
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutationsHannes Armbruster, Tilman Schotte, Isabell Götting, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
BJU International|May 8, 2024
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC MonitorMaximilian Haas, Maximilian C Kriegmair, Johannes Breyer, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Virchows Archiv : an International Journal of Pathology|July 19, 2024
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancerFabienne Lange, Carol I Geppert, Veronika Bahlinger, et al.
Immunotargets and Therapy|May 7, 2026
B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile CancerAleksander Kielbik, Veronika Bahlinger, Christian M Schürch, et al.
International Journal of Molecular Sciences|June 27, 2024
Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer PatientsCedric Smolka, Markus Eckstein, Rudolf Jung, et al.
International Journal of Molecular Sciences|September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and SubtypingStefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
European Urology Open Science|June 16, 2025
Clinical and Genomic Landscape of <i>FGFR3</i> Alterations Across Different Stages of Urothelial CancerMaximilian Haas, Roman Mayr, Danijel Sikic, et al.
Frontiers in Immunology|October 29, 2024
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevanceAnnalena Branz, Christian Matek, Fabienne Lange, et al.
Communications Biology|December 30, 2025
Nanosecond pulsed electric fields induce cell-size-dependent selective permeabilization of urothelial cancer cellsAleksander Kielbik, Emily Hellwich, Veronika Bahlinger, et al.
Virchows Archiv : an International Journal of Pathology|August 27, 2024
Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutationsHannes Armbruster, Tilman Schotte, Isabell Götting, et al.
Histopathology|January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohortsVeronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
BJU International|May 8, 2024
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC MonitorMaximilian Haas, Maximilian C Kriegmair, Johannes Breyer, et al.
Pageof 3